Age, Biography and Wiki
Hans-Georg Rammensee was born on 12 April, 1953 in Tübingen, Germany, is an A german immunologist. Discover Hans-Georg Rammensee's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 70 years old?
| Popular As |
N/A |
| Occupation |
immunologist |
| Age |
70 years old |
| Zodiac Sign |
Aries |
| Born |
12 April 1953 |
| Birthday |
12 April |
| Birthplace |
Tübingen, Germany |
| Nationality |
Germany
|
We recommend you to check the complete list of Famous People born on 12 April.
He is a member of famous with the age 70 years old group.
Hans-Georg Rammensee Height, Weight & Measurements
At 70 years old, Hans-Georg Rammensee height not available right now. We will update Hans-Georg Rammensee's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Hans-Georg Rammensee Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Hans-Georg Rammensee worth at the age of 70 years old? Hans-Georg Rammensee’s income source is mostly from being a successful . He is from Germany. We have estimated Hans-Georg Rammensee's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Hans-Georg Rammensee Social Network
Timeline
Hans-Georg Rammensee (born 12 April 1953) is a German immunologist and cancer researcher.
Since the late 1970s, Rammensee has been focusing on immunology with the specific aim of using tumor immunology to fight against cancer.
He has contributed to genetics and immune regulation as well as to the understanding of minor H antigens, T cells and the major histocompatibility complex (MHC).
His group has systematically developed bioinformatics tools for this purpose.
In recent years, Rammensee has combined basic research on MHC biology with translational research, thus bringing tumor immunology into clinical practice.
Currently he is focusing on the development of individualized cancer immunotherapy.
After gaining his doctorate in 1982 he initially worked as a post-doctoral research fellow at Scripps Research Institute, La Jolla, USA.
In 1985 he moved as a scientific member to the Basel Institute for Immunology, Basel, Switzerland.
Two years later Rammensee returned to Max Planck Institute for Biology as a group leader at the department of immunogenetics.
1993 he became head of department at the Tumor-Virus-Immunology Section of the German Cancer Research Center, Heidelberg, Germany.
The same year he was appointed professor at the Faculty of Theoretical Medicine of Heidelberg University.
He has been Chair Professor and Head of the Department of Immunology at the University of Tübingen since 1996.
Rammensee has contributed essentially to the research fields of MHC biology and tumor immunology and to the development of cancer immunotherapies.
Rammensee studied Biology at the University of Tübingen and worked as a PhD student at the Max Planck Institute for Biology in Tübingen.
He has been a Full Professor at the University of Tübingen and Chair of the Department of Immunology at the Institute for Cell Biology since 1996.
In 2000 and 2010, Rammensee co-founded three research-based companies.
Immatics is involved in the development of cancer immunotherapies, CureVac develops therapies based on messenger RNA (mRNA); synimmune on recombinant antibodies.
